Active Ingredient History
Aminohippurate (p-aminohippuric acid, PAH, PAHA) is the glycine amide of p-aminobenzoic acid. Aminohippuric acid sodium salt is an agent to measure effective renal plasma flow (ERPF). NCATS
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bariatric Surgery (Phase 2)
Cardiovascular Diseases (Phase 1)
Diabetes Complications (Phase 1/Phase 2)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Phase 1/Phase 2)
Diabetic Nephropathies (Phase 1/Phase 2)
Endothelial Cells (Phase 1)
Healthy Volunteers (Phase 4)
Heart Failure (Phase 4)
Hypertension (Phase 1)
Insulin Resistance (Phase 1)
Kidney Diseases (Phase 2)
Obesity (Phase 1/Phase 2)
Pediatric Obesity (Phase 1/Phase 2)
Tuberculosis (Phase 1)
Weight Loss (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue